Completed Diabetes, Hormones & Metabolism Cancer

CD4 T cell differentiation and regulation in autoimmune diabetes

In plain English

AI plain-English summary

A particular subset of immune cells—follicular helper T cells—has been identified as the likely culprit behind type 1 diabetes in mice. This matters because current treatments for type 1 diabetes suppress the entire immune system, leaving patients vulnerable to infections and other side effects. The disease occurs when immune cells attack the pancreas, destroying insulin production. Even transplanted insulin-producing cells get destroyed. Until now, researchers did not know which specific immune cells drive the attack, making targeted treatment impossible. This project pinpoints follicular helper T cells as the key players. If this research succeeds, it could lead to therapies that selectively eliminate or block only these disease-causing cells, leaving the rest of the immune system intact. The team will first confirm whether the same cell type appears in blood samples from human patients, then test whether targeting these cells can prevent or reverse diabetes in mouse models. A successful outcome would shift treatment from blanket immune suppression to precision targeting—a change that could dramatically reduce side effects for people living with type 1 diabetes.

View original technical description
Type 1 diabetes is an autoimmune disease in which cells of the immune system attack the pancreas and prevent it from producing insulin. Even if new insulin-producing cells are provided as a transplant, the immune system simply destroys these too. Medicines are available that suppress the entire immune system, but these have unwanted side effects. The key to successful treatment of type 1 diabetes is to pinpoint which cells cause disease so that these can be selectively targeted. We have performed a screen to characterise the immune cells that cause diabetes in a mouse model. This work has yielded a striking result; the cells are quite clearly a particular subset called follicular helper T cells. The possibility that this subset of immune cells could cause diabetes has not previously been explored. The proposed work seeks to investigate how these cells develop, and determine whether targeting this subset therapeutically can prevent or reverse diabetes. We will explore whether follicular helper T cells can be detected in blood samples from type 1 diabetes patients and will also take advantage of mouse diabetes models so we can test whether targeting these cells has beneficial effects.

View the original record at the funder ↗

Researchers

Lucy Walker (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Thymic and peripheral T cell tolerance in autoimmune diabetes
The role of B cell regulation in type 1 diabetes in NOD mice
Using an animal model of type 1 diabetes to identify biomarkers of pre-symptomatic disease and treatment efficacy
Investigating follicular helper T cells as biomarkers and new therapeutic targets in autoimmune diabetes
Immunomodulation of type I diabetes by pharmacologically-enhanced delivery of regulatory T cells

Original classification

Fellowship

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.